FTH-002

N/A

Report date: 2024/08/21 15:58:24
NME

Base Information

Drug NameFTH-002
Drug Alias NameFTH-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsRectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFaeth Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFaeth Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsRectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A